IU Today

Know

Lilly and IU to expand access to clinical trials and latest innovative treatments for Hoosiers

A new agreement under which Eli Lilly and Company will provide up to $40 million to IU aims to expand access to clinical trials in Indiana, giving patients a critical pathway to Lilly’s latest investigational and innovative medicines while surrounding them with exceptional care.

December 3

Explore the impact